Santarus (SNTS)

Add to Watchlists Create an Alert
22.38 -0.55  -2.40%   NASDAQ May 24, 10:17AM BATS Real time Currency in USD

Santarus SG&A Expense Quarterly:

30.75M for March 31, 2013
View Full Chart

Santarus SG&A Expense Quarterly Chart

    Santarus Historical SG&A Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 30.75M
    Dec. 31, 2012 24.98M
    Sept. 30, 2012 21.13M
    June 30, 2012 20.59M
    March 31, 2012 19.85M
    Dec. 31, 2011 19.48M
    Sept. 30, 2011 16.15M
    June 30, 2011 16.12M
    March 31, 2011 16.48M
    Dec. 31, 2010 16.12M
    Sept. 30, 2010 15.00M
    June 30, 2010 24.93M
    March 31, 2010 26.54M
    Dec. 31, 2009 25.46M
    Sept. 30, 2009 26.33M
    June 30, 2009 27.33M
    March 31, 2009 28.54M
    Dec. 31, 2008 49.48M
    Sept. 30, 2008 28.52M
    June 30, 2008 25.75M
    March 31, 2008 Go Pro
       
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro

    About SG&A Expense

    SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

    The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
    Learn More

    Get data for

    SNTS SG&A Expense Quarterly Benchmarks

    Companies
    Jazz Pharmaceuticals 70.53M
    Catalyst Pharmaceutical Partners 0.7607M
    Salix Pharmaceuticals 76.27M

    SNTS SG&A Expense Quarterly Rankings

    Overall 75th percentile
    1939 of 8009
    Sector 76th percentile
    161 of 687 in Healthcare
    Industry 90th percentile
    24 of 248 in Biotechnology

    SNTS SG&A Expense Quarterly Range, Past 5 Years

    Minimum 15.00M Sep 2010
    Maximum 49.48M Dec 2008
    Average 23.98M